Gossamer Bio, Inc.
NASDAQGossamer Bio reports Thursday with one fact dominating the setup: nearly 17% of the free float is sold short. That is a meaningful bearish overhang for a stock trading at $0.34, down 21% over the past month despite a modest 4% recovery in the latest week. Short sellers have been lightening up, however — and that nuance matters. Short interest fell roughly 1.3% over the past week to…
Snapshot as of 5 Jul 2026
Gossamer Bio reports Thursday with one fact dominating the setup: nearly 17% of the free float is sold short. That is a meaningful bearish overhang for a stock trading at $0.34, down 21% over the past month despite a…
Gossamer Bio shares tumbled 19% this week to $0.36, tracking analysts' bearish pivot after disappointing trial data. Short interest fell 3% week-over-week to 15.4% of float, while borrowing costs eased and utilisation…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for GOSS — free to start on ORTEX.
Sign up for free →Open GOSS on ORTEX